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Abstract 
Background: HLA genes are the most polymorphic of the human genome and have distinct allelic frequencies in 
populations of different geographical regions of the world, serving as genetic markers in ancestry studies. In addition, 
specific HLA alleles may be associated with various autoimmune and infectious diseases. The bone marrow donor 
registry in Brazil is the third largest in the world, and it counts with genetic typing of HLA‑A, ‑B, and ‑DRB1. Since 1991 
Brazil has maintained the DATASUS database, a system fed with epidemiological and health data from compulsory 
registration throughout the country.
Methods: In this work, we perform spatial analysis and georeferencing of HLA genetic data from more than 86,000 
bone marrow donors from Rio Grande do Sul (RS) and data of hospitalization for rheumatoid arthritis, multiple scle‑
rosis and Crohn’s disease in RS, comprising the period from 1995 to 2016 obtained through the DATASUS system. The 
allele frequencies were georeferenced using Empirical Bayesian Kriging; the diseases prevalence were georeferenced 
using Inverse Distance Weighted and cluster analysis for both allele and disease were performed using Getis‑Ord Gi* 
method. Spearman’s test was used to test the correlation between each allele and disease.
Results: The results indicate a HLA genetic structure compatible with the history of RS colonization, where it is pos‑
sible to observe differentiation between regions that underwent different colonization processes. Spatial analyzes of 
autoimmune disease hospitalization data were performed revealing clusters for different regions of the state for each 
disease analyzed. The correlation test between allelic frequency and the occurrence of autoimmune diseases indi‑
cated a significant correlation between the HLA‑B*08 allele and rheumatoid arthritis.
Conclusions: Genetic mapping of populations and the spatial analyzes such as those performed in this work have 
great economic relevance and can be very useful in the formulation of public health campaigns and policies, con‑
tributing to the planning and adjustment of clinical actions, as well as informing and educating professionals and the 
population.
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Background
Harboring more than 200 genes spread over a 3.6  Mb 
region, the Major Histocompatibility Complex (MHC) 
is the region of the human genome most enriched for 
open reading frames [1]. MHC genes, or HLA (Human 
Leukocyte Antigen) genes in humans, are the most pol-
ymorphic loci of the human genome [2], showing dif-
ferent allelic frequencies in populations from different 
geographic regions around the world [3–5]. Due to their 
high genetic variability and strong linkage disequilib-
rium, HLA genes have been used in studies of genetic 
ancestry and demography [6]. Due to their major role 
in immune response, the loci of the HLA system are the 
primary determinants of tolerance or rejection in organ 
and hematopoietic stem cell transplantation (HSCT) [7]. 
HSCT from bone marrow is clinically indicated for the 
treatment of disorders of the hematopoietic system or 
the immune system and in cases of malignant bone mar-
row diseases and disseminated solid tumors. Leukemia 
is the leading indication for allogeneic HSCT (72%), fol-
lowed by lymphoproliferative diseases (15%), non-malig-
nant diseases (12%) and solid tumors (0.6%) [8, 9].
In addition, specifc HLA alleles have already been asso-
ciated with various autoimmune and infectious diseases 
[10, 11]. As a class, the overall cumulative prevalence 
for all autoimmune diseases (AD) is 5.0%, being 3.0% for 
males and 7.1% for females [12]. Rheumatoid arthritis 
(RA) is the most prevalent AD (0.5–1%) [13], being the 
HLA-DRB1 is the principal locus contributing to disease 
susceptibility, with an estimated contribution of 30–50% 
to overall susceptibility to RA [14, 15]. Other AD, such 
as Celiac Disease, Type 1 Diabetes Mellitus, Ankylosing 
spondylitis, Multiple sclerosis and Crohn’s disease also 
presented HLA genes associated with its susceptibility 
[see [16] and [17] for further review]. Thus, knowledge 
of HLA diversity at the population level is important 
to guide public health policies focused on AD and to 
improve bone marrow transplantation programs.
The use of the geographic information system (GIS)—
a toolkit for capturing, storing, transforming, analyzing 
and presenting spatial data—has been a powerful tool 
in assessing and monitoring public health in different 
populations around the world [18, 19]. GIS-based data 
contributes to the improvement of health-related ser-
vices for the population, since health data combined with 
geographic information allow researchers to analyze the 
spatial variation of diseases, mortality, morbidity, access 
to health care systems and social or environmental deter-
minants for health outcomes [20, 21]. The transformation 
of detailed data into maps can facilitate communication 
of the geographical distribution of health challenges in 
different communities and identify areas for intervention 
[18, 22].
The Brazilian Bone Marrow Donor Registry 
(REDOME, in Portuguese) is the third largest bank of 
bone marrow donors in the world, with more than 4 mil-
lion donors registered to date. The state of Rio Grande do 
Sul (RS), in southern Brazil, has the fourth largest num-
ber of registered donors in Brazil, with approximately 
300,000 individuals. This register contains information 
of HLA-A, -B and -DRB1 genotypes, city of residence of 
the donor as well as ethnicity by self-declaration based on 
skin color. In this work, we used GIS tools to evaluate the 
spatial correlation between immune system alleles (from 
HLA-A, -B and -DRB1 loci) and occurrence of AD in Rio 




We analyzed a dataset containing 97,292 potential bone 
marrow donors residing in the state of Rio Grande do Sul 
who voluntarily registered in REDOME between Janu-
ary 2008 and December 2012. Rio Grande do Sul, the 
southernmost state of Brazil, is the fourth largest state of 
the country with more than 11 million inhabitants dis-
tributed in 497 cities [23], 439 of which are represented 
in the dataset. At the time of registration in REDOME, 
the individuals declared their ethnicity by auto-percep-
tion based on skin color, following Brazilian Institute of 
Geography and Statistics (IBGE) standards. Only munici-
palities with 50 or more registered donors were included 
in the analysis. For self-reported white individuals (or 
Euro-descendants, EURD), 120 cities distributed across 
all regions of the state cities met the sample size criteria 
(Additional file  1), totaling 86,672 individuals (Fig.  1). 
On the other hand, only 19 cities had more than 50 self-
reported black (or Afro-descendants, AFRD) individuals, 
scattered across the state and, therefore, excluded from 
further analyses.
Genotyping for HLA-A, -B and -DRB1 loci was per-
formed at the Hospital das Clínicas de Porto Alegre 
(HCPA) (Luminex LABType SSO system; One Lambda, 
Inc., Canoga Park, CA). Due to the high polymorphism 
of HLA genes, complete identification of each allele is 
only possible through sequencing-based typing. Thus, 
Luminex genotyping identifies only “low resolution” 
allelic groups. Because they are closely located on the 
same chromosome, HLA alleles segregate in linkage 
blocks, known as haplotypes.
Information on AD were available in DATASUS 
(Department of Informatics of the Unified Health Sys-
tem, in Portuguese), a database established by the Bra-
zilian Ministry of Health since 1991 that contains health 
information and statistics from all municipalities in Bra-
zil and that is publicly available through online access 
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(datasus.saude.gov.br/datasus). In general, the DATASUS 
database is fed by data sent by the municipal and state 
health secretariats to the Ministry of Health. Of the 497 
cities of Rio Grande do Sul, 496 had information about 
AD hospitalizations in DATASUS database.
This study was approved by the Ethics Committee of 
the Research and Post-Graduation Group of the Hospital 
de Clínicas de Porto Alegre, under number 386.216.
Statistical analyses
Allele and haplotype frequency estimations and tests of 
Hardy–Weinberg equilibrium (HWE) were performed 
using the GENE[RATE] tools as described elsewhere [7, 
24–26]. Principal component analysis (PCA) was done 
for each locus using Rstudio (v0.98.1103) and the genetic 
structure was measured using the synthetic genetic 
structure (SPC) measure proposed by Xue et al. [27], as 
follows:
where PC is the component score and W is the propor-
tion (weight) of the component contribution. All com-
ponents with an eigenvalue greater than 1 were included 
in the SPC calculation, following the Kaiser criterion 
[28]. Hospitalization data for RA, multiple sclerosis 
(MS), Crohn’s disease (CD) and leukemia for each city, 
comprising the period from January 1995 to December 
2016, were obtained through the DATASUS system (tab-
net.datasus.gov.br/). RA, MS and CD are the only AD 
recorded in DATASUS. The number of hospitalizations 
SPC = W1 × PC1 +W2 × PC2 + · · · +Wk × PCk
Fig. 1 Rio Grande do Sul and its Meso‑regions. Red dots indicate the cities included in the study for HLA data
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of each disease in each city was adjusted by the num-
ber of inhabitants and used as an indicator of disease 
prevalence (disease index, DI). Spearman’s correlation 
test between each allele and each disease was performed 
using IBM SPSS software, Version 20.0 (IBM Corp., 
Armonk, NY). The result obtained in the Spearman cor-
relation test was submitted to the multiple comparison 
test FDR (false discovery rate) in Rstudio (v0.98.1103) 
using the stats (3.3.0) package.
Allele and haplotype frequency, SPC data as well as 
positive and statistically significant alleles × diseases 
(hereafter A*D) in the Spearman’s correlation test were 
spatially interpolated using the Empirical Bayesian Krig-
ing method (EBK). For each interpolation, scatterplots 
were performed for the observed and predicted values 
and calculated their respective coefficients of determina-
tion  (R2),  Spearman’s correlation coefficient (ρ), Spear-
man’s coefficient of determination (ρ2) and the root mean 
square error (RMSE). The P-values were adjusted by FDR 
for α = 0.05.
Cluster maps for A*D showing positive and statistically 
significant correlation in the Spearman test were gener-
ated through the Hot-Spot analysis using the Getis-Ord 
Gi* method [29, 30] based on the following formula:
where DI is the disease index, DImax is the maximum 
disease index, DImin is the minimum disease index, AF is 
the allelic frequency, AFmax is the maximum allelic fre-
quency and AFmin is the minimum allele frequency. All 
spatial analyses were performed in ArcGis v10.3.
Results
For all cities, allele frequencies did not show deviations 
from the Hardy–Weinberg equilibrium (Additional 
file  2). Considering the whole state, the most frequent 
alleles for each locus were HLA-A*02 (27.6%), HLA-B*35 
(12.4) and HLA-DRB1*07 (13.4%), with substantial allele 
frequency variation among cities (Additional files 2, 3). 
Five haplotypes reached frequencies above 2% in at least 
one city. Haplotype A*01 ~ B*08 ~ DRB1*03 presented the 
highest frequency considering the entire state (3.7%). Fol-
lowing allele frequencies, there was substantial variation 
in haplotype frequencies among cities (Additional files 
4, 5). Figure  2 shows the spatial HLA genetic structure 
based on SPC in Rio Grande do Sul. HLA-A and HLA-B 
loci have a very similar structure, showing a higher dif-
ferentiation between the Southwest and Metropolitan 
regions in relation to the Central and Northwest regions. 
The HLA-DRB1 locus presents a slightly different struc-







combined data for the three loci, shows a very similar 
structure compared to HLA-A and HLA-B.
Figure  3 shows the distribution of the DI, while dis-
ease prevalence is shown, for each city, in Additional 
file  6. The small town of União da Serra, located in the 
Northeast region of the state, has a population of approx-
imately 1500 inhabitants, which is equivalent to 0.014% 
of the total population of the state of Rio Grande do Sul. 
However, this city responded to 0.162% of all hospitali-
zations for RA from January 1995 to December 2016 (62 
hospitalizations events). Thus, when considering the 
number of hospitalizations by the number of inhabitants 
in relation to the totals for the state, União da Serra is 
the municipality with the highest prevalence of RA with 
a DI 11.6 × higher than expected. Similarly, the town 
of São Sepé, in the Center-East region of the state, was 
the city with the highest prevalence for MS, with a DI 
almost 9 × higher than expected. On its turn, the town 
of São Pedro da Serra, in the Metropolitan region, had 
the highest prevalence for CD, with a DI 9.5 × higher 
than expected. For leukemia, the towns of Pouso Novo, 
in the Center-East region, Vista Alegre and Três Arroios, 
both in the Northwest region, had a DI 4.5 × higher than 
the expected. For all diseases (CD, MS, RA, and leuke-
mia) there was strong evidence for spatial clusters in DI 
(Fig. 4, Additional file 7, P < 3 × 10−5 in all cases). Differ-
ent regions appeared as hot-spots for different diseases. 
The Center-East and Northeast regions behaved as hot-
spots for RA and MS, while the Metropolitan and the 
Northwest regions were cold-spots. CD had a hot-spot 
cluster in the Metropolitan region and in a small area in 
the Northeast, while for leukemia there was a hot-spot in 
the extreme North of the state.
Table  1 shows the Spearman correlation index (ρ) 
for each allele and each disease tested. Most of the sta-
tistically significant correlations found were negative. 
Alleles HLA-B*08 and -DRB1*03 showed a positive 
and significant correlation with RA; HLA-B*08 with 
MS; and HLA-A*29, HLA-B*38 and HLA-DRB1*01 
with CD. Cluster analyses indicated a significant spa-
tial component in A*D interaction for HLA-B*08 × RA, 
HLA-DRB1*03 × RA, HLA-B*08 × MS (P < 0.01), and 
HLA-A*29 × CD (P < 0.05), which is represented in Fig. 5 
(and in Additional file 8). However, only the correlation 
between HLA-B*08 and RA remained significant after 
FDR correction. Interestingly, spatial hot-spots for A*D 
differ from DI hot-spots, indicating that adding genetic 
information on top of disease prevalence results in new 
insights of disease epidemiology.
The Spearman’s correlation coefficient (ρ), Spearman’s 
coefficient of determination (ρ2) and the root mean square 
error (RMSE) for all observed and interpolated values of 
each EBK map (allelic and haplotypic frequencies, SPC 
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analysis and A*D correlation analysis) are presented in the 
Additional file  9. The lowest correlation coefficient was 
0.1686 for allele HLA-B*56 and the highest was 0.9978 for 
HLA-A*30. The lowest RMSE found was < 0.0001 for allele 
HLA-B*27, while the highest was 0.1628 for SPC HLA-
DRB1. Except for the HLA-A*68 and HLA-B*56 allele 
frequency maps, all interpolations were statistically sig-
nificant, even after FDR correction. Scatterplots and their 
respective coefficient of determination  (R2) for each inter-
polated map are presented in Additional file 10.
Discussion
This is the first study to perform spatial analysis of HLA 
genetic structure, correlating HLA population genetics 
data with epidemiological data on AD. Figure  1 shows 
the HLA structure of the bone marrow donor popula-
tion in Rio Grande do Sul based on the principal compo-
nent analysis (PCA) of HLA allele frequencies. Visually, 
HLA-A, HLA-B and the combined data for the three loci 
showed a very similar structure, presenting a higher dif-
ferentiation between the Southwest and Metropolitan 
regions in relation to the Central and Northwest regions.
PCA is a very useful tool in the investigation of popula-
tion structure, but sampling strategy and the amount of 
data may impact its results [31]. In this study, only self-
reported white individuals were included due to sample 
size limitations (only 19 cities had more than 50 self-
reported black individuals, with little coverage in the 
state). It is unlikely that this had a major impact on the 
characterization of HLA genetic structure in Rio Grande 
Fig. 2 HLA heterogeneity and its genetic structure estimated by SPC and spatialized by EBK. a HLA‑A locus. b HLA‑B locus. c HLA‑DRB1 locus. d 
HLA‑A, ‑B and ‑DRB1 loci combined
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do Sul as a whole, given that more than 80% of the pop-
ulation of Rio Grande do Sul is self-declared white [23], 
and more than 90% of REDOME donors in Rio Grande 
do Sul declare themselves white at the time of registra-
tion. However, given that there are differences in AD 
prevalence between black and white individuals [32, 33, 
see 34 for review], an important step forward would be 
characterizing geographic clusters of AD in the black 
population of this state and its relationship with the clus-
ters identified in this study.
Among the classic HLA genes, HLA-A is more sensi-
tive to demographic processes, such as genetic drift, 
because it is less affected by balancing selection [35, 36]. 
In this sense, the differentiation between the Southwest, 
Southeast and the Metropolitan regions, on one hand, 
compared to the Central and Northwest regions, on the 
other hand (Fig. 1), may mirror the colonization history 
of Rio Grande do Sul (Additional file  11). In these for-
mer regions, Portuguese and Spanish individuals were 
the major settlers since the early eighteenth century, with 
the later arrival of African slaves, mostly in the Pelotas 
(Southeast) region. On the other hand, Germans (1824), 
Poles (1871) and Italians (1875) were major ethnicities 
settling the Central and Northern regions [37, 38].
Specific spatialization and interpolation techniques 
may influence the geographic trends shown by the data. 
In this study, allele and haplotype frequencies as well as 
A*D positive and statistically significant correlations 
were spatialized by the EBK method (Additional files 3, 
5). This method was chosen because we had only 120 
Fig. 3 Maps of AD and leukemia prevalence in Rio Grande do Sul. a Rheumatoid arthritis. b Multiple sclerosis. c Crohn’s disease. d Leukemia. Data 
obtained from the DATASUS system comprising the period from January 1995 to June 2016 (tabnet.datasus.gov.br/)
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points to represent the 496 municipalities of Rio Grande 
do Sul. Kriging is a probabilistic predictor, thus assum-
ing a statistical model for the data, being able to quantify 
the uncertainty associated with the values predicted from 
the standard errors. This method uses a semivariogram—
a function of distance and direction separating two loca-
tions—to quantify the spatial dependence on the data. 
EBK differs from classical kriging by using many semi-
variogram models rather than using only a single model. 
For each repetition, the semivariogram is used to simu-
late a new set of values at the input sites; then the simu-
lated data are used to estimate a new semivariogram and 
its weight. Thus, predicted values and standard errors are 
inferred for the non-sampled regions using these weights 
[39].
All interpolated maps showed correlation between 
observed and interpolated values. The lowest correla-
tion coefficients were typically observed in alleles with 
low frequencies, and where the sampling is conse-
quently smaller. It is important to note that the alleles 
that showed a positive and significant correlation with 
AD (HLA-A*29, HLA-B*08, HLA-B*38, HLA-DRB1*01 
e HLA-DRB1*03) presented a correlation coefficient for 
interpolation ranging from 0.513 to 0.982 and maximum 
RMSD of 0.017 (Additional file 9). These values indicate 
that the interpolation method and the analyses per-
formed are consistent.
The Hot-Spot analysis (Getis-Ord Gi*) revealed geo-
graphic clusters of AD (RA, MS and CD) and leukemia 
in Rio Grande do Sul, indicating that neighbor regions 
Fig. 4 Cluster maps for AD and leukemia in Rio Grande do Sul. a Rheumatoid arthritis. b Multiple sclerosis. c Crohn’s disease. d Leukemia
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should have similar disease prevalence (Additional 
file  7). On the other hand, our analysis also revealed 
spatial clusters of A*D, even though both spatial clus-
ters had little overlap (Figs. 4, 5). A genetic cluster can 
be defined as a group of genetically divergent individu-
als that arises when gene flow is impeded by physical 
or cultural barriers [40]. Evolutionary forces such as 
the founder’s effect and low immigration may reinforce 
genetic backgrounds that pre-dispose to some genetic 
conditions. One interpretation for the little overlap 
between DI and A*D is that while DI spatial cluster-
ing is dominated by shared environmental and genetic 
(non-HLA) affecting disease status, A*D spatial clusters 
indicate a more important role for the common HLA 
genetic background (through specific “risk” alleles) 
for these diseases. As a result, cities having a high fre-
quency of HLA-B*08, for example, will have a higher 
chance of having high DI for RA even if this city is dis-
tant from the DI spatial cluster disconsidering HLA 
information.
Table 1 Spearman correlation (ρ) between alleles and diseases
RA Rheumatoid arthritis, MS multiple sclerosis, CD Crohn’s disease
Italic: Positive correlation; P ≤ 0.05
*Remained significant even after correction by FDR
HLA-A RA MS CD HLA-B RA MS CD HLA-DRB1 RA MS CD
A*01 0.124 0.072 − 0.198 B*07 0.146 0.135 − 0.079 DRB1*01 0.016 − 0.088 0.187
A*02 − 0.018 − 0.008 − 0.125 B*08 0.327* 0.218 − 0.005 DRB1*03 0.210 0.102 0.036
A*03 0.008 0.021 − 0.072 B*13 0.046 0.037 − 0.143 DRB1*04 0.054 0.162 − 0.249
A*11 − 0.108 − 0.118 − 0.089 B*14 − 0.077 − 0.049 0.100 DRB1*07 − 0.182 − 0.117 0.143
A*23 − 0.166 − 0.255 − 0.017 B*15 0.077 0.083 − 0.020 DRB1*08 − 0.220 − 0.168 0.066
A*24 − 0.059 − 0.084 0.036 B*18 0.169 0.056 0.027 DRB1*09 − 0.089 − 0.091 − 0.004
A*25 0.150 0.075 − 0.113 B*27 0.094 0.067 − 0.199 DRB1*10 − 0.059 − 0.008 0.101
A*26 0.045 0.002 0.149 B*35 0.029 − 0.013 0.125 DRB1*11 0.046 0.032 0.112
A*29 − 0.207 − 0.203 0.197 B*37 − 0.178 − 0.157 0.028 DRB1*12 − 0.121 − 0.150 − 0.180
A*30 − 0.131 − 0.055 0.172 B*38 − 0.038 − 0.111 0.195 DRB1*13 − 0.115 − 0.060 − 0.094
A*31 − 0.040 − 0.085 − 0.003 B*39 − 0.017 − 0.060 0.158 DRB1*14 − 0.066 − 0.077 − 0.005
A*32 0.093 0.133 − 0.119 B*40 − 0.034 0.001 − 0.248 DRB1*15 0.047 0.030 − 0.015
A*33 − 0.011 0.034 0.088 B*41 − 0.156 − 0.136 − 0.096 DRB1*16 − 0.230 − 0.265 − 0.084
A*34 − 0.313 − 0.229 0.065 B*42 − 0.111 − 0.047 0.167
A*36 − 0.149 − 0.123 0.149 B*44 − 0.179 − 0.089 0.022
A*43 0.020 0.073 − 0.054 B*45 − 0.211 − 0.178 0.024
A*66 − 0.110 − 0.090 0.014 B*46 0.073 0.052 0.038
A*68 0.056 0.043 0.149 B*47 − 0.155 − 0.168 0.028
A*69 − 0.126 − 0.120 − 0.016 B*48 − 0.218 − 0.120 0.049
A*74 − 0.197 − 0.185 0.089 B*49 − 0.123 − 0.148 0.004
A*80 − 0.143 − 0.072 − 0.016 B*50 − 0.371 − 0.306 0.088
B*51 − 0.007 0.006 0.031
B*52 0.019 0.026 0.150
B*53 − 0.200 − 0.148 0.078
B*54 0.091 0.101 0.078
B*55 − 0.120 − 0.188 − 0.067
B*56 − 0.015 0.052 0.066
B*57 0.010 0.027 − 0.077
B*58 − 0.191 − 0.182 0.076
B*59 − 0.099 − 0.083 − 0.001
B*67 − 0.010 0.004 − 0.042
B*73 − 0.106 − 0.069 0.005
B*78 − 0.050 0.002 − 0.006
B*81 − 0.289 − 0.242 0.012
B*82 − 0.098 − 0.064 0.106
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AD are heterogeneous in regard to prevalence, clini-
cal manifestations, and pathogenesis, being caused by an 
immune response against constituents of the body’s own 
tissues. Specific HLA alleles can predispose to several AD 
[10, 11]. Indeed, some of the positive and significant cor-
relations between HLA alleles and AD found in our study 
have already been described in case–control studies. Han 
et  al. [41] established a relationship between HLA-B*08 
and RA subtype anti-citrullinated-protein-autoantibody-
negative  (ACPA− or seronegative) in a study involving 
2406  ACPA− case and 13,930 control individuals. Alsaied 
et  al. [42] found an association between HLA-DRB1*03 
and juvenile RA in Kuwaiti Arab children, and Manivel 
et  al. [43] established an association between HLA-
DRB1*03 and RA subtype anti-CII (anti fibrillar colla-
gen type II) in the Swedish population. On the contrary, 
Lysandropoulos et al. [44] tested the relation between MS 
and HLA-B*08, but the result was inconclusive. Concern-
ing CD, Goyette et al. [45] found a significant association 
with DRB1*01, but there are no other studies correlat-
ing CD and HLA-A*29 and HLA-B*38. Differently from 
our findings, Konda Mohan et al. [46] ] and Bizzari et al. 
[47] indicated a protective role for HLA-DRB1*03 for 
RA in Indian and Arabic populations, respectively. These 
results may indicate that some relationships between AD 
and HLA background may be population-specific, which 
highlights the potential of spatial analyses to identify 
small-scale A*D clusters in populations from a similar 
background.
Nonetheless, some limitations of this study should be 
taken into account: the bone marrow donor individuals 
are not the same reported in the DATASUS system for 
the mentioned diseases, in addition to the already men-
tioned limiting number of cities having enough sample 
Fig. 5 Cluster maps for allele × autoimmune disease interaction. a HLA‑B*08 × RA. b HLA‑DRB1*03 × RA. c HLA‑B*08 × MS. d and HLA‑A*29 × CD
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size for allele frequency analysis. Besides, the data used 
in the DATASUS system refers to the number of hos-
pitalizations for each disease and, because we use data 
of chronic disease, the same person may hospitalize 
more than once for the same condition. However, spa-
tially studies can serve at least as preliminary models of 
genetic × disease interaction to guide further investiga-
tions and promote public health actions.
Understanding the demographic processes that affect 
the genetic diversity of human populations at a spatial 
scale can be useful in public health policies in the pre-
sent. The study of the HLA diversity at the population 
level is invaluable in disease-association studies and in 
the effectiveness of bone marrow transplantation pro-
grams. Thus, the results presented in this study, such as 
the heterogeneous genetic structure and the A*D spatial 
correlations, demonstrate the importance of the inte-
grated use of large databases with spatial-specific analy-
sis approaches, and may indicate the need to implement 
space-specific interventions to guide policy planning and 
decision making in public health.
Despite all the potential use of GIS, this tool is still 
underutilized in public health centers around the world. 
Georeferencing is an essential first step in making it pos-
sible to analyze public health data geographically [48]. 
Through the georeferencing of public health data it is 
possible to perform a spatial analysis for public health 
systems [49]. The correct use of GIS can inform and 
educate professionals and the public, give more power 
to decision making at all levels, assist in planning and 
adjusting clinical and cost-effective actions, monitor and 
analyze changes in health levels and exposure to disease 
[50].
Conclusions
In this study, we used GIS tools to evaluate the spatial 
correlation between HLA alleles and occurrence of AD 
in Rio Grande do Sul, based on data available from gov-
ernmental health agencies. To the best of our knowledge, 
this is the first study that investigates the spatial corre-
lation between genetic data and AD occurrence. The 
results presented in this study highlights the potential of 
spatial analyses to identify the interaction between alleles 
and diseases in populations from a similar background. 
The use of information from large databases such as 
REDOME and DATASUS together with georeferencing 
tools can help in the identification of useful markers in 
population genetics that may confer resistance or suscep-
tibility to diseases. Genetic mapping of populations and 
the spatial analyzes such as those performed in this work 
have great economic relevance and can be very useful in 
the formulation of public health campaigns and policies, 
contributing to the planning and adjustment of clinical 
actions, as well as informing and educating professionals 
and the population.
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